A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia
Clinical trial NCT04899310 · TERMINATED
Trial details
- NCT number
- NCT04899310
- Sponsor
- ModernaTX, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2026-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.